These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 25601365)

  • 1. Discontinuation of buprenorphine maintenance therapy: perspectives and outcomes.
    Bentzley BS; Barth KS; Back SE; Book SW
    J Subst Abuse Treat; 2015 May; 52():48-57. PubMed ID: 25601365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient Perspectives Associated with Intended Duration of Buprenorphine Maintenance Therapy.
    Bentzley BS; Barth KS; Back SE; Aronson G; Book SW
    J Subst Abuse Treat; 2015 Sep; 56():48-53. PubMed ID: 25899872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The real-world impact of dosing of methadone and buprenorphine in retention on opioid agonist therapies in Ukraine.
    Farnum SO; Makarenko I; Madden L; Mazhnaya A; Marcus R; Prokhorova T; Bojko MJ; Rozanova J; Dvoriak S; Islam Z; Altice FL
    Addiction; 2021 Jan; 116(1):83-93. PubMed ID: 32428276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release from incarceration, relapse to opioid use and the potential for buprenorphine maintenance treatment: a qualitative study of the perceptions of former inmates with opioid use disorder.
    Fox AD; Maradiaga J; Weiss L; Sanchez J; Starrels JL; Cunningham CO
    Addict Sci Clin Pract; 2015 Jan; 10(1):2. PubMed ID: 25592182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prior National Drug Abuse Treatment Clinical Trials Network (CTN) opioid use disorder trials as background and rationale for NIDA CTN-0100 "optimizing retention, duration and discontinuation strategies for opioid use disorder pharmacotherapy (RDD)".
    Shulman M; Weiss R; Rotrosen J; Novo P; Costello E; Nunes EV
    Addict Sci Clin Pract; 2021 Mar; 16(1):15. PubMed ID: 33676577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of buprenorphine maintenance treatment as compared to a syringe exchange program among buprenorphine misusing opioid-dependent patients.
    Aalto M; Visapää JP; Halme JT; Fabritius C; Salaspuro M
    Nord J Psychiatry; 2011 Sep; 65(4):238-43. PubMed ID: 21047194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population.
    Morgan JR; Schackman BR; Leff JA; Linas BP; Walley AY
    J Subst Abuse Treat; 2018 Feb; 85():90-96. PubMed ID: 28733097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Medication-assisted treatment with buprenorphine: assessing the evidence.
    Thomas CP; Fullerton CA; Kim M; Montejano L; Lyman DR; Dougherty RH; Daniels AS; Ghose SS; Delphin-Rittmon ME
    Psychiatr Serv; 2014 Feb; 65(2):158-70. PubMed ID: 24247147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary care-based buprenorphine taper vs maintenance therapy for prescription opioid dependence: a randomized clinical trial.
    Fiellin DA; Schottenfeld RS; Cutter CJ; Moore BA; Barry DT; O'Connor PG
    JAMA Intern Med; 2014 Dec; 174(12):1947-54. PubMed ID: 25330017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of barriers to adoption of buprenorphine maintenance therapy by family physicians.
    DeFlavio JR; Rolin SA; Nordstrom BR; Kazal LA
    Rural Remote Health; 2015; 15():3019. PubMed ID: 25651434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Buprenorphine Treatment and 12-step Meeting Attendance: Conflicts, Compatibilities, and Patient Outcomes.
    Monico LB; Gryczynski J; Mitchell SG; Schwartz RP; O'Grady KE; Jaffe JH
    J Subst Abuse Treat; 2015 Oct; 57():89-95. PubMed ID: 25986647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations between prescribed benzodiazepines, overdose death and buprenorphine discontinuation among people receiving buprenorphine.
    Park TW; Larochelle MR; Saitz R; Wang N; Bernson D; Walley AY
    Addiction; 2020 May; 115(5):924-932. PubMed ID: 31916306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harm Reduction Agencies as a Potential Site for Buprenorphine Treatment.
    Fox AD; Chamberlain A; Frost T; Cunningham CO
    Subst Abus; 2015; 36(2):155-60. PubMed ID: 25837290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Supportive alternate site provision of buprenorphine: Overcoming barriers and improving patient outcomes.
    Khan A; Khan Q; Kolb E
    J Subst Abuse Treat; 2021 Apr; 123():108256. PubMed ID: 33612191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent incarceration and buprenorphine maintenance treatment outcomes among human immunodeficiency virus-positive patients.
    Riggins DP; Cunningham CO; Ning Y; Fox AD
    Subst Abus; 2017; 38(3):297-302. PubMed ID: 27715904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 'Too little dose - too early discontinuation?'-Effect of buprenorphine dose on short term treatment adherence in opioid dependence.
    Muruganandam P; Shukla L; Sharma P; Kandasamy A; Chand P; Murthy P
    Asian J Psychiatr; 2019 Aug; 44():58-60. PubMed ID: 31325758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescribing Characteristics Associated With Opioid Overdose Following Buprenorphine Taper.
    Bozinoff N; Men S; Kurdyak P; Selby P; Gomes T
    JAMA Netw Open; 2022 Sep; 5(9):e2234168. PubMed ID: 36173629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Smoking Cessation Methods Among Patients Receiving Office-based Buprenorphine Maintenance Treatment.
    Shah PA; Cunningham CO; Brisbane MT; DeLuca JP; Nahvi S
    J Addict Med; 2017; 11(6):494-497. PubMed ID: 28885300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buprenorphine Maintenance Treatment of Opiate Dependence: Correlations Between Prescriber Beliefs and Practices.
    MacDonald K; Lamb K; Thomas ML; Khentigan W
    Subst Use Misuse; 2016 Jan; 51(1):85-90. PubMed ID: 26771870
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute Care, Prescription Opioid Use, and Overdose Following Discontinuation of Long-Term Buprenorphine Treatment for Opioid Use Disorder.
    Williams AR; Samples H; Crystal S; Olfson M
    Am J Psychiatry; 2020 Feb; 177(2):117-124. PubMed ID: 31786933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.